Skip to main content
Premium Trial:

Request an Annual Quote

SIDMAP Introduces Metabolomic Profiling Technology, Services

NEW YORK, Sept. 2 (GenomeWeb News) - SIDMAP, a Los Angeles-based startup, on Wednesday introduced a metabolic profiling technology service based on a proprietary tracer-molecule technology and mass spectrometry.


The company, named after its Stable Isotope-based Dynamic Metabolic Profiling technology, is commercializing the approach as a service targeting drug discovery and development. The SIDMAP technology uses labeled metabolic substrate molecules (tracers) to track disease-characteristic metabolic pathways.


The technology was developed at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center by Laszlo Boros, an associate professor of pediatrics at the University of California, Los Angeles, and Paul Lee, UCLA professor of pediatrics, the company said in a statement.


SIDMAP has licensed the technology from LA Biomed. Financial details of the agreement were not disclosed, the company said.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.